Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Contraception
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Contraception
    TopAbstracts in Contraception 06/30/2009 - (DGNews)
    TopAbstracts in Contraception 06/02/2009 - (DGNews)
    Levonorgestrel Intrauterine System Shows Benefits for Women With Abnormal Bleeding, Dysmenorrhoea: Presented at ACOG - (DGDispatch)
    Longer Regimen of Drospirenone/Ethinylestradiol Oral Contraceptives More Effective Than Shorter Regimen or Other Progestins: Presented at ACOG - (DGDispatch)
    Oestradiol Valerate/Dienogest Birth Control Pill Appears Effective: Presented at ACOG - (DGDispatch)

    News archive

     Recent webcasts/CME - Contraception
    • Some Anti-Epileptic Drugs May Compromise Bone Health
    • Balancing Treatment With Reproductive Health in Women With Epilepsy
    • Improving Contraceptive Success: Facilitating Choice of Appropriate and Acceptable Contraceptive Methods
      Sterilization Methods for Women
      Gynecologic and Colorectal Cancer: Risks and Benefits of Contraceptive Methods

      Webcasts/CME archive

       Recent cases - Contraception
        Refractory Thrombotic Thrombocytopenic Purpura Associated with Oral Contraceptives and Factor V Leiden: A Case Report
        Foreign Body Granuloma in the Anterior Abdominal Wall Mimicking an Acute Appendicular Lump and Induced by a Translocated Copper-T Intrauterine Contraceptive Device: A Case Report
        Co-Existence of a Giant Splenic Hemangioma and Multiple Hepatic Hemangiomas and the Potential Association With the Use of Oral Contraceptives: A Case Report
        Pelvic Actinomycosis Presenting with a Large Abscess and Bowel Stenosis with Marked Response to Conservative Treatment: A Case Report
        The Sexually Active Adolescent Who is Uncertain about Using Contraception

        Cases archive
          




        my personal edition > contraception > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Oral Contraceptive Use and Risk of Death Restricted to Smokers

        Lancet

        07/24/2003
        By Martha Kerr


        Use of oral contraceptives (OCs) has no adverse effect on overall mortality, but heavy smokers who use Ocs have a more than two-fold higher risk of death from ischaemic heart disease, a large study of 17,032 women reported recently.

        Martin Vessey, MD, emeritus professor of public health, University of Oxford, United Kingdom, and colleagues analysed 889 deaths that occurred over 30 years in women enrolled in the Oxford Family Planning Association (Oxford FPA) study. The women were either never users of OCs or were users for more than 8 years.

        For all causes of mortality, the rate ratio for death was 0.89 for OC users overall. For the subgroup of women who smoked 14 cigarettes or fewer per day, the rate ratio was 1.24, and for those who smoked 15 or more cigarettes per day, the rate ratio for death was 2.14.

        There was no increased risk of death from breast cancer among OC users, Dr. Vessey and colleagues note. "Indeed, our results suggest the reverse," they state. On the other hand, smokers had more than double the risk of death from ischaemic heart disease.

        "The effect of heavy smoking in our study is large, and [is] similar to that reported by others. Our results suggest that the risk associated with oral contraceptive use is confined to smokers, which is consistent with most other work."

        Dr. Vessey notes that the average dose of oestrogen among these users of OCs in this long-term study was 50 mcg, "a high dose by current standards."

        He points out that, while the findings of this study cannot be applied to users of the current low-dose formulations, "they do nonetheless offer considerable encouragement."
        Lancet 2003;362:185-191.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send